Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties
Publication
, Journal Article
Schechter, LE; Smith, DL; Rosenzweig-Lipson, S; Sukoff, SJ; Dawson, LA; Marquis, K; Jones, D; Piesla, M; Andree, T; Nawoschik, S; Harder, JA ...
Published in: Journal of Pharmacology and Experimental Therapeutics
September 2005
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Journal of Pharmacology and Experimental Therapeutics
DOI
EISSN
1521-0103
ISSN
0022-3565
Publication Date
September 2005
Volume
314
Issue
3
Start / End Page
1274 / 1289
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Related Subject Headings
- Pharmacology & Pharmacy
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Schechter, L. E., Smith, D. L., Rosenzweig-Lipson, S., Sukoff, S. J., Dawson, L. A., Marquis, K., … Childers, W. (2005). Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties. Journal of Pharmacology and Experimental Therapeutics, 314(3), 1274–1289. https://doi.org/10.1124/jpet.105.086363
Schechter, L. E., D. L. Smith, S. Rosenzweig-Lipson, S. J. Sukoff, L. A. Dawson, K. Marquis, D. Jones, et al. “Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties.” Journal of Pharmacology and Experimental Therapeutics 314, no. 3 (September 2005): 1274–89. https://doi.org/10.1124/jpet.105.086363.
Schechter LE, Smith DL, Rosenzweig-Lipson S, Sukoff SJ, Dawson LA, Marquis K, et al. Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties. Journal of Pharmacology and Experimental Therapeutics. 2005 Sep;314(3):1274–89.
Schechter, L. E., et al. “Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties.” Journal of Pharmacology and Experimental Therapeutics, vol. 314, no. 3, American Society for Pharmacology & Experimental Therapeutics (ASPET), Sept. 2005, pp. 1274–89. Crossref, doi:10.1124/jpet.105.086363.
Schechter LE, Smith DL, Rosenzweig-Lipson S, Sukoff SJ, Dawson LA, Marquis K, Jones D, Piesla M, Andree T, Nawoschik S, Harder JA, Womack MD, Buccafusco J, Terry AV, Hoebel B, Rada P, Kelly M, Abou-Gharbia M, Barrett JE, Childers W. Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties. Journal of Pharmacology and Experimental Therapeutics. American Society for Pharmacology & Experimental Therapeutics (ASPET); 2005 Sep;314(3):1274–1289.
Published In
Journal of Pharmacology and Experimental Therapeutics
DOI
EISSN
1521-0103
ISSN
0022-3565
Publication Date
September 2005
Volume
314
Issue
3
Start / End Page
1274 / 1289
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Related Subject Headings
- Pharmacology & Pharmacy
- 1115 Pharmacology and Pharmaceutical Sciences